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Recent studies in cancer biology have changed the traditional view of tumor progression,
showing that the growth and evolution of many cancers are driven by a population of cells
named Cancer Stem Cells (CSCs) [3]. In detail, the CSCs theory describes these tumors as
hierarchically structured, and characterized by di↵erent subpopulations of cells. This het-
erogeneity is considered the cause of the failure of many conventional treatments. Indeed,
even if many current treatments are able to kill the di↵erentited tumor cell populations,
they do not have the same positive e↵ect on CSCs. In fact, cancer stem cells resist to most
of the common cancer therapies, causing the tumor relapse. Therefore, it is fundamental to
fully understand mechanisms underlying these type of tumors, in order to better understand
their progression and treatments responses.
Mathematical models about cell populations dynamics ([4], [5] and [1]) provide a useful
tool to achieve these goals. In particular, in this paper we present a compartmental mathe-
matical model which describes the progression of a type of malignant tumors characterized
by the stem-di↵erentiation hierarchy. In our model the dynamics of cell populations are
described by a system of non linear ordinary di↵erential equations (ODEs), on which we
perform both a qualitative and quantitative analysis. More precisely, we start fixing the
qualitative behavior of the system through the equilibria structure definition and the stabil-
ity investigation. Then, we analyze model temporal evolution by its numerical integration.
Furthermore, before this quantitative phase, we set up model parameters in order to de-
scribe data related to the breast cancer evolution [2]. We find some interesting analytical
properties of system equilibria that allow us to reduced the huge parameters space. Even-
tually, we apply this tool to a real breast cancer case study [2], in order to predict the
vaccination e↵ects on its progression.
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